Fitz-Hugh-Curtis Syndrome

Comprehensive Clinical Guide: Fitz-Hugh-Curtis Syndrome (FHCS)

Fitz-Hugh-Curtis Syndrome (FHCS), also historically referred to as perihepatitis, represents a rare but clinically significant complication of pelvic inflammatory disease (PID). It is defined as the inflammation of the hepatic capsule and the adjacent peritoneum, leading to the formation of characteristic "violin-string" adhesions between the liver capsule and the anterior abdominal wall or diaphragm.

While historically associated primarily with Neisseria gonorrhoeae, modern clinical literature confirms that Chlamydia trachomatis is the most common etiological agent in the modern era. This guide serves as a definitive clinical resource for medical professionals, detailing the pathophysiology, diagnostic pathways, and long-term management strategies for FHCS.

1. Pathophysiology and Mechanism of Action

The pathogenesis of Fitz-Hugh-Curtis Syndrome is rooted in the ascending spread of infection from the endocervix to the upper genital tract, eventually reaching the peritoneal cavity.

The Mechanism of Spread

1. Ascent: The infection migrates from the lower genital tract to the fallopian tubes, causing salpingitis.
2. Peritoneal Dissemination: Bacteria, inflammatory exudates, and cytokines travel upward via the paracolic gutters (the anatomical spaces between the lateral aspect of the ascending/descending colon and the abdominal wall).
3. Hepatic Involvement: The inflammatory process reaches the Glisson’s capsule (the connective tissue covering of the liver) and the right hemidiaphragm.
4. Adhesion Formation: The body’s inflammatory response involves fibrin deposition. Over time, these fibrin deposits organize into dense, fibrous adhesions—the hallmark "violin-string" appearance observed during laparoscopy.

Histological Characteristics

• Acute Phase: Characterized by purulent exudate, hyperemia, and edema of the liver capsule and peritoneum.
• Chronic Phase: Characterized by dense, fibrous, avascular bands of connective tissue connecting the liver to the abdominal wall.

2. Clinical Presentation and Staging

Diagnosis is frequently missed due to the overlap of symptoms with cholecystitis, pleurisy, and musculoskeletal pain.

Classic Presentation

• Right Upper Quadrant (RUQ) Pain: Often sharp, pleuritic in nature, and exacerbated by deep inspiration, coughing, or movement.
• Referred Pain: Pain may radiate to the right shoulder due to phrenic nerve irritation.
• Pelvic Symptoms: While often present, the patient may be asymptomatic regarding the original PID (silent PID).
• Constitutional Symptoms: Fever, malaise, and nausea are common during the acute phase.

Clinical Grading (Modified)

While no universally standardized staging system exists, clinicians often categorize the severity based on the extent of peritoneal involvement:

3. Diagnostic Modalities

Diagnosis requires a high index of suspicion, especially in reproductive-age women presenting with RUQ pain.

Laboratory Investigations

• Nucleic Acid Amplification Tests (NAAT): The gold standard for detecting C. trachomatis and N. gonorrhoeae in cervical/vaginal swabs.
• Inflammatory Markers: Elevated Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP).
• Liver Function Tests (LFTs): Typically normal in FHCS, which helps distinguish it from primary hepatocellular disease or cholecystitis.

Imaging Techniques

• Ultrasound (Transabdominal): Often limited, but may show perihepatic fluid or gallbladder wall thickening (secondary to reactive inflammation).
• Computed Tomography (CT) with Contrast: The diagnostic modality of choice. Findings include:
  • Enhancement of the liver capsule (the "perihepatic enhancement" sign).
  • Absence of gallbladder pathology (ruling out cholecystitis).
  • Potential findings of pelvic adnexal masses.
• Laparoscopy: The definitive gold standard. Allows for direct visualization of the "violin-string" adhesions and permits adhesiolysis if necessary.

4. Differential Diagnosis

The clinical mimicry of FHCS is extensive. Clinicians must rule out the following:

1. Biliary Disease: Cholecystitis, choledocholithiasis, or biliary colic.
2. Pulmonary Pathology: Right lower lobe pneumonia or pulmonary embolism (given the pleuritic nature of the pain).
3. Gastrointestinal Pathology: Peptic ulcer disease, appendicitis (if the appendix is retrocecal), or inflammatory bowel disease.
4. Musculoskeletal: Costochondritis or nerve root irritation.

5. Standard Treatment Protocols

Treatment is primarily medical, focusing on the underlying infectious etiology.

Pharmacological Intervention

The antibiotic regimen must cover the spectrum of PID-causing pathogens:
* First-line: Ceftriaxone (250–500 mg IM) plus Doxycycline (100 mg BID for 14 days) with or without Metronidazole.
* Duration: Typically 14 days to ensure complete eradication of the upper tract infection.

Surgical Intervention

Surgery is rarely indicated for the acute phase. Laparoscopic adhesiolysis is reserved for patients with:
1. Chronic, debilitating RUQ pain that is refractory to conservative medical therapy.
2. Diagnostic uncertainty where malignancy or acute surgical abdomen cannot be ruled out.

6. Risks, Complications, and Prognosis

Potential Complications

• Chronic Pelvic Pain: Due to persistent adhesions and sequelae of PID.
• Infertility: Resulting from tubal scarring and occlusion.
• Ectopic Pregnancy: Increased risk due to tubal damage.
• Recurrence: If sexual partners are not treated or if re-infection occurs.

Long-term Prognosis

With prompt antibiotic therapy, the prognosis is excellent. The inflammation of the liver capsule generally resolves without long-term liver dysfunction. However, the fibrous adhesions may persist, leading to chronic, intermittent RUQ pain.

7. FAQ Section: Expert Insights

1. Is Fitz-Hugh-Curtis Syndrome considered a liver disease?
No. It is a perihepatitis—an inflammation of the capsule of the liver—not an intrinsic disease of the liver parenchyma. Liver function tests usually remain within normal limits.

2. Can men develop Fitz-Hugh-Curtis Syndrome?
It is extremely rare in men. While the causative bacteria can infect men, the anatomical pathway to the liver capsule is typically blocked by the absence of the female reproductive tract anatomy that facilitates the ascent of the infection in the peritoneum.

3. Why is the pain worse when taking a deep breath?
The pain is pleuritic because the inflamed liver capsule and the diaphragm move against each other during respiration. Deep breathing increases the friction between these inflamed surfaces.

4. Does FHCS lead to cirrhosis?
No. Because the inflammation is limited to the Glisson’s capsule and does not involve the hepatocytes themselves, it does not lead to scarring of the liver tissue (cirrhosis).

5. How is the diagnosis confirmed if tests are negative?
If blood tests and NAATs are negative but clinical suspicion remains high, laparoscopy is the only way to confirm the presence of characteristic adhesions.

6. Do I need to be hospitalized for treatment?
Hospitalization is generally reserved for patients who are systemically ill (high fever, vomiting) or who have failed oral antibiotic therapy.

7. Can the "violin-string" adhesions be seen on an X-ray?
No. Adhesions are soft-tissue densities that do not show up on standard plain-film X-rays. They are best visualized via laparoscopy or occasionally inferred via CT enhancement patterns.

8. Is sexual abstinence required during treatment?
Yes. Patients should abstain from sexual intercourse until both they and their partners have completed the full course of antibiotic therapy and symptoms have resolved.

9. Can FHCS cause infertility?
FHCS is a marker of severe PID. The infertility risk is associated with the tubal scarring caused by the PID, rather than the liver capsule inflammation itself.

10. What is the "Perihepatic Enhancement" sign on CT?
It is a radiological finding where the liver capsule shows increased contrast density during the arterial phase of a CT scan, indicating active inflammation.

8. Conclusion

Fitz-Hugh-Curtis Syndrome is a classic example of how pelvic pathology can manifest in the upper abdomen. As medical professionals, maintaining a high index of suspicion in young women presenting with pleuritic RUQ pain is vital. By utilizing NAAT for screening and CT imaging for confirmation, clinicians can provide timely antibiotic therapy, effectively preventing the long-term morbidity associated with chronic PID and adhesion formation.

This guide underscores the necessity of interdisciplinary communication between gynecologists, internal medicine specialists, and radiologists to ensure patient-centered care and optimal clinical outcomes.

Disclaimer: This guide is intended for clinical educational purposes and does not replace professional medical judgment or institutional protocols. Always consult the latest CDC guidelines regarding the treatment of Sexually Transmitted Infections.